Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;84(4):e19-e21.
doi: 10.1016/j.jinf.2022.01.043. Epub 2022 Feb 3.

The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients

Haoran Cui  1 , Jiaxin Liu  2 , Leiliang Zhang  3
Affiliations

The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients

Haoran Cui et al. J Infect. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that there are no conflicts of interest.

Figures

Fig 1
Fig. 1
The expression levels of key components of NLRP3-inflammasome and pyroptosis including NEK7 (A), NLRP3 (B), CASP1 (C), ASC (D) and GSDMD (E) in cancer patients. ns, no significance; ∗, P < 0.05.
Fig 2
Fig. 2
All five key components of NLRP3-inflammasome and pyroptosis we examined were up-regulated in LAML (A) and PAAD (B) patients.
See this image and copyright information in PMC

Comment in

References

    1. Afshar Z.M., Dayani M., Naderi M., Ghanbarveisi F., Shiri S., Rajati F. Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis. J Infect. 2020;81:e114–e116. - PMC - PubMed
    1. Ma J., Yin J., Qian Y., Wu Y. Clinical characteristics and prognosis in cancer patients with COVID-19: a single center's retrospective study. J Infect. 2020;81:318–356. - PMC - PubMed
    1. Qin G., Yang J., Zhao C., Ren J., Qu X. The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors. J Infect. 2021 doi: 10.1016/j.jinf.2021.12.011. - DOI - PMC - PubMed
    1. Qiu S., Zhang Y., Wang D., Hu Y. The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients. J Infect. 2021;83:709–737. - PMC - PubMed
    1. Vora S.M., Lieberman J., Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol. 2021;21:694–703. - PMC - PubMed

Publication types

Substances